Kanagawa-ken, Japan

Kazue Yaegashi


Average Co-Inventor Count = 12.6

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazue Yaegashi: Innovator in Platelet Aggregation Inhibitors

Introduction

Kazue Yaegashi is a prominent inventor based in Kanagawa-ken, Japan. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit platelet aggregation. With a total of three patents to her name, her work has the potential to impact medical treatments significantly.

Latest Patents

One of her latest patents focuses on compounds with platelet aggregation inhibitor activity. This patent discloses a compound represented by the general formula (I) and a pharmaceutically acceptable salt and solvate thereof, which has an effect for inhibiting the agglutination of platelets. The specific structure includes R.sup.1 representing a group --W--(CH.sub.2).sub.i --COOR.sup.3, showcasing her innovative approach to addressing critical health issues.

Career Highlights

Kazue Yaegashi is associated with Meiji Seika Kabushiki Kaisha, a well-known company in the pharmaceutical industry. Her work at this organization has allowed her to focus on research and development, leading to her notable patents.

Collaborations

Throughout her career, Kazue has collaborated with esteemed colleagues such as Kiyoaki Katano and Shokichi Ohuchi. These partnerships have fostered an environment of innovation and creativity, contributing to the advancement of their shared research goals.

Conclusion

Kazue Yaegashi's contributions to the field of platelet aggregation inhibitors highlight her role as a leading inventor in pharmaceutical sciences. Her innovative patents and collaborations reflect her commitment to advancing medical research and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…